0001144204-15-023363.txt : 20150417 0001144204-15-023363.hdr.sgml : 20150417 20150416181605 ACCESSION NUMBER: 0001144204-15-023363 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150415 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20150417 DATE AS OF CHANGE: 20150416 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alcentra Capital Corp CENTRAL INDEX KEY: 0001578620 IRS NUMBER: 000000000 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 814-01064 FILM NUMBER: 15776204 BUSINESS ADDRESS: STREET 1: 200 PARK AVENUE STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10166 BUSINESS PHONE: 212-922-8240 MAIL ADDRESS: STREET 1: 200 PARK AVENUE STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10166 FORMER COMPANY: FORMER CONFORMED NAME: Alcentra Capital Corp. DATE OF NAME CHANGE: 20130605 8-K 1 v407532_8k.htm FORM 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

 

Pursuant to section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): April 15, 2015

 

 

Alcentra Capital Corporation

(Exact name of registrant as specified in its charter)

 

Maryland   1-36447   46-2961489

(State or other jurisdiction of

incorporation or organization)

 

(Commission

File Number)

 

(IRS Employer

Identification Number)

 

200 Park Avenue, 7th Floor
New York, NY 10166

(Address of principal executive offices)

 

Registrant’s telephone number, including area code (212) 922-8240

 

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

Item 7.01.    Regulation FD Disclosure.

 

On April 16, 2015, the registrant issued a press release, included herewith as Exhibit 99.1, announcing the completion of its public offering of unsecured notes.

 

The information disclosed under this Item 7.01, including Exhibit 99.1 hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be deemed incorporated by reference into any filing made under the Securities Act of 1933, except as expressly set forth by specific reference in such filing.

  

Item 9.01     Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
     
99.1   Press release dated April 16, 2015.

 

 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: April 17, 2015 ALCENTRA CAPITAL CORPORATION
     
  By:  /s/ Paul J. Echausse
   

Name: Paul J. Echausse

Title: Chief Executive Officer and President

 

 
 

 

EXHIBIT INDEX

 

Exhibit No.   Description
     
99.1   Press release dated April 16, 2015.

 

 

 

EX-99.1 2 v407532_ex99-1.htm PRESS RELEASE

 

Exhibit 99.1

 

Alcentra Capital Corporation Announces Successful Completion of $40 million Unsecured Note Offering

 

NEW YORK— April 16, 2015 (BUSINESS WIRE) – Alcentra Capital Corporation (NASDAQ Global Select Market: “ABDC”) (“Alcentra”) announced today that Alcentra has successfully completed the issuance of $40 million in aggregate principal amount of unsecured notes (the “Notes”). The Notes have maturities from five to seven years and a weighted average interest rate of 6.38%. Approximately 85% of the Notes were purchased by institutional investors, with the remainder purchased by retail investors. Net proceeds from the issuance of the Notes will be used to reduce outstanding borrowings on Alcentra’s revolving credit facility.

 

“We are excited to welcome a new group of investors as part of our investor base and appreciate the support provided by the institutional investors that participated in our Note offering,” said Paul Echausse, CEO and President of Alcentra Capital Corporation.

 

 

About Alcentra Capital Corporation

 

Alcentra (www.alcentracapital.com) is an externally-managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940. Alcentra’s investment objective is to generate both current income and capital appreciation primarily by making direct investments in lower middle-market companies in the form of subordinated debt and, to a lesser extent, senior debt and minority equity investments. Alcentra’s investment activities are managed by its investment adviser, Alcentra NY, LLC.

 

About Alcentra NY, LLC

 

Alcentra NY, LLC is part of BNY Alcentra Group Holdings, Inc. (“Alcentra Group”), one of the world’s leading sub-investment grade credit asset managers focusing on the U.S. and European markets. Alcentra Group has an investment track record that spans across more than 75 separate investment funds totaling approximately $22 billion (including accounts managed by Alcentra NY, LLC, Alcentra Ltd, and assets managed by Alcentra Group personnel for affiliates under dual officer arrangements.)

 

FORWARD-LOOKING STATEMENTS

 

Statements included herein may contain “forward-looking statements,” which relate to future performance or financial condition. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance or results and involve a number of assumptions, risks and uncertainties, which change over time. Actual results may differ materially from those anticipated in any forward-looking statements as a result of a number of factors, including those described from time to time in filings by the Company with the Securities and Exchange Commission. Alcentra undertakes no duty to update any forward-looking statement made herein except as required by law. All forward-looking statements speak only as of the date of this press release.

 

 
 

 

Contacts

 

Paul Echausse

Chief Executive Officer and President

212- 922-8960

paul.echausse@alcentra.com

 

Ellida McMillan
Chief Accounting Officer

212- 922- 6644

ellida.mcmillan@alcentra.com